FDA Adverse Event Injury Summary report: N

LINEAR? ST

MDR report key: 24329537 · Received February 12, 2026

Report

Report Number
3006630150-2026-00869
Event Type
Injury
Date Received
February 12, 2026
Date of Event
December 29, 2025
Report Date
May 14, 2026
Manufacturer
BOSTON SCIENTIFIC NEUROMODULATION CORPORATION
Product Code
LGW
UDI-DI
08714729784067
PMA / PMN Number
P030017
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TX, US
Reporter Occupation
PHYSICIAN
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

BLOCK B3: EXACT DATE UNKNOWN, DATE OF LEAD PULL WAS USED AS EVENT OCCURRED POST-TRIAL. INVESTIGATION RESULTS. THE DEVICES WERE NOT RETURNED FOR ANALYSIS; THEREFORE, A TECHNICAL ANALYSIS COULD NOT BE PERFORMED. THE PHYSICIAN CONFIRMED THAT INFECTION WAS NOT PROCEDURE RELATED AND UNKNOWN IF IT WAS RELATED TO THE DEVICE. THE PATIENT WAS ADMINISTERED WITH ANTIBIOTICS AND WAS STABLE UPON FOLLOW-UP. THE REMOVED LEADS WERE NOT RETURNED. DEVICE HISTORY RECORD. IT WAS CONFIRMED THIS DEVICE MET MANUFACTURING SPECIFICATION PRIOR TO DISTRIBUTION AND THERE WERE NO MANUFACTURING DEVIATIONS WHICH COULD HAVE CONTRIBUTED TO THE REPORTED EVENT. LABELING REVIEW. REVIEW OF THE INSTRUCTIONS FOR USE (IFU) CONFIRMED THERE WAS RELEVANT CONTENT AND SUFFICIENT GUIDANCE WITH RESPECT TO THE CIRCUMSTANCES DESCRIBED WITHIN THIS COMPLAINT. NO UPDATES ARE REQUIRED TO THE IFU AS A RESULT OF THIS EVENT. INVESTIGATION CONCLUSION. BASED ON A THOROUGH REVIEW OF THE REPORTED COMPLAINT, BOSTON SCIENTIFIC HAS ASSIGNED AN INVESTIGATION CONCLUSION CODE OF KNOWN INHERENT RISK OF DEVICE.

Additional Manufacturer Narrative · 0

ADDITIONAL SUSPECT MEDICAL DEVICE COMPONENT INVOLVED IN THE EVENT: PRODUCT FAMILY: SCS-LINEAR LEADS UPN: M365SC221850E0 MODEL: SC-2218-50E SERIAL: (B)(6). BATCH: 7173196 UDI: (B)(4).

Additional Manufacturer Narrative · 0

BLOCK B3: EXACT DATE UNKNOWN, DATE OF LEAD PULL WAS USED AS EVENT OCCURRED POST-TRIAL.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT DEVELOPED AN INFECTION AROUND THE LEAD INSERTION SITE FOLLOWING THE TRIAL PROCEDURE. THE PHYSICIAN CONFIRMED THAT INFECTION WAS NOT PROCEDURE RELATED AND UNKNOWN IF IT WAS RELATED TO THE DEVICE. THE PATIENT WAS ADMINISTERED WITH ANTIBIOTICS AND WAS STABLE UPON FOLLOW-UP. THE REMOVED LEADS WERE NOT RETURNED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT DEVELOPED AN INFECTION AROUND THE LEAD INSERTION SITE FOLLOWING THE TRIAL PROCEDURE. THE PHYSICIAN CONFIRMED THAT INFECTION WAS NOT PROCEDURE RELATED AND UNKNOWN IF IT WAS RELATED TO THE DEVICE. THE PATIENT WAS ADMINISTERED WITH ANTIBIOTICS AND WAS STABLE UPON FOLLOW-UP. THE REMOVED LEADS WERE NOT RETURNED.

Description of Event or Problem · 0

IT WAS REPORTED THAT THE PATIENT DEVELOPED AN INFECTION AROUND THE LEAD INSERTION SITE FOLLOWING THE TRIAL PROCEDURE. THE PHYSICIAN CONFIRMED THAT INFECTION WAS NOT PROCEDURE RELATED AND UNKNOWN IF IT WAS RELATED TO THE DEVICE. THE PATIENT WAS ADMINISTERED WITH ANTIBIOTICS AND WAS STABLE UPON FOLLOW-UP. THE REMOVED LEADS WERE NOT RETURNED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
35971 LINEAR? ST STIMULATOR, SPINAL-CORD, TOTALLY IMPLANTED FOR PAIN RELIEF LGW BOSTON SCIENTIFIC NEUROMODULATION CORPORATION SC-2218-50E 7166999 08714729784067

Patients

Seq Age Sex Outcome Treatment
1 67 YR Female Required Intervention